Twist Bioscience Corp (TWST)
31.53
+0.45
(+1.45%)
USD |
NASDAQ |
Apr 26, 16:00
31.53
0.00 (0.00%)
After-Hours: 18:18
Twist Bioscience Enterprise Value: 1.486B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.486B |
| April 24, 2024 | 1.467B |
| April 23, 2024 | 1.510B |
| April 22, 2024 | 1.392B |
| April 19, 2024 | 1.305B |
| April 18, 2024 | 1.329B |
| April 17, 2024 | 1.341B |
| April 16, 2024 | 1.343B |
| April 15, 2024 | 1.379B |
| April 12, 2024 | 1.463B |
| April 11, 2024 | 1.578B |
| April 10, 2024 | 1.531B |
| April 09, 2024 | 1.639B |
| April 08, 2024 | 1.595B |
| April 05, 2024 | 1.574B |
| April 04, 2024 | 1.538B |
| April 03, 2024 | 1.617B |
| April 02, 2024 | 1.592B |
| April 01, 2024 | 1.678B |
| March 28, 2024 | 1.673B |
| March 27, 2024 | 1.682B |
| March 26, 2024 | 1.640B |
| March 25, 2024 | 1.668B |
| March 22, 2024 | 1.689B |
| March 21, 2024 | 1.772B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.736B |
| March 19, 2024 | 1.644B |
| March 18, 2024 | 1.645B |
| March 15, 2024 | 1.634B |
| March 14, 2024 | 1.687B |
| March 13, 2024 | 1.744B |
| March 12, 2024 | 1.701B |
| March 11, 2024 | 1.820B |
| March 08, 2024 | 1.861B |
| March 07, 2024 | 1.885B |
| March 06, 2024 | 1.891B |
| March 05, 2024 | 1.816B |
| March 04, 2024 | 1.900B |
| March 01, 2024 | 1.937B |
| February 29, 2024 | 1.961B |
| February 28, 2024 | 2.016B |
| February 27, 2024 | 2.059B |
| February 26, 2024 | 2.036B |
| February 23, 2024 | 1.898B |
| February 22, 2024 | 1.922B |
| February 21, 2024 | 1.907B |
| February 20, 2024 | 1.973B |
| February 16, 2024 | 2.053B |
| February 15, 2024 | 2.088B |
| February 14, 2024 | 1.993B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
268.48M
Minimum
May 02 2023
9.527B
Maximum
Jan 20 2021
2.277B
Average
1.446B
Median
Jun 08 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 931.55M |
| Retractable Technologies Inc | -13.79M |
| Xtant Medical Holdings Inc | 133.46M |
| Asensus Surgical Inc | 44.48M |
| Catheter Precision Inc | 0.7844M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.01M |
| Revenue (Quarterly) | 71.50M |
| Total Expenses (Quarterly) | 118.48M |
| EPS Diluted (Quarterly) | -0.75 |
| Gross Profit Margin (Quarterly) | 40.51% |
| Profit Margin (Quarterly) | -60.15% |
| Earnings Yield | -11.45% |
| Normalized Earnings Yield | -10.78 |